Human Microbiome-based Gut Health Test and Nutrition Market Growth and Restrain Factors Analysis Report

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Human Microbiome-based Gut Health Test and Nutrition Market - By Product (D2C Gut Health Test, Probiotic Supplements, Personalized Nutrition, Microbiome Modulators) and Future Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

According to the latest research report, the global human microbiome-based gut health test and nutrition market is valued at US$ 110.83 Million in 2021, and it is expected to reach US$ 885.52 Million by 2030, with a CAGR of 27.2% during the forecast period of 2022-2030. By Region, North America dominated the market with a significant share in 2021.

Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/1221

A human gut microbiome is a collection of beneficial and harmful microorganisms prevalent in the human body's digestive tract. The human intestine contains numerous microorganisms of thousands of species, including bacteria, fungi, parasites, and viruses. Microbiota supports the immune system by degrading potentially toxic food compounds and synthesizing specific vitamins and amino acids, including all B vitamins and vitamin K. Stool tests, are used to diagnose the health of a population and the digestive health of humans using gut health test kits. These exams provide individualized results and suggestions for nutritional supplementation. Immunity, physical and mental health, and other benefits depend on preserving gut health and the appropriate balance of these microorganisms.
Due to the impact of COVID-19, consumers are more aware of the importance of good immunity, gut health, and gut health testing, which will spur manufacturing and research into gut microbiome nutrition. Rapid advances in microbiome diagnostic testing and a growing understanding of the microbiota's role in disease development are anticipated to drive market growth over the forecast period. In addition, global Consumer Packaged Goods (CPG) companies, innovative start-ups, and biotechs will play an essential role in expanding the global market. Increasing collaborations between public and private organizations are anticipated to generate significant growth opportunities over the foreseeable future.
However, the high consumption of antibiotics and other supplements is anticipated to hinder the global market. Understanding the gut microbiome is complicated by the wide variation in human genetic makeup, dietary patterns, and international distribution.

Due to increased demand and the enormous impact of COVID-19, North America is anticipated to experience brisk expansion over the forecast period (2022-2030). Companies receive substantial funding for research on live microbiome ingredients and product development.

Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1221

The important key players are Seed Health, ResBiotic, Fitbiomics, HSK Genetech, Mybacs, Affinity DNA, Freshly fermented, Carbiotix, Troo, Verisana, Throne, Phable, Biomesight, Invivo, Neovos, Holobiome, The BioArte, Bio & Me, ISOThrive, Zarbees, Mamasselect, Hyperbiotics, Everidis, Floraster, Enfamil, Culturelle, Biogaia, Viome, Atlas Biomed, Nouri, Bayer Consumer Health, Clasado Biosciences, CometBio, Essential formulae, ExeGi, Kerry, Immune Biotech, Pendulum Therapeutics, Evolve Biosystems, Gerber, Lovebug probiotics, Mommy's Bliss, Flore, Bioms, Ombre, Biohm, Nexbiome, Finch Therapeutics, Byheart, Mybiotics, Vedanta Biosciences, Other Prominent Players

Key developments in the market:
• In Jan 2022, Unilever has associated with the gut microbiome specialists at Holobiome to identify food & drink ingredients that could have a positive effect on mental wellbeing by targeting the gut-brain axis. The research partnership between Unilever and Holobiome attempts to find specific dietary ingredients that interact with these important bacteria. The long-term goal is to use these substances in a variety of foods and beverage products across Unilever's portfolio to naturally increase levels of calming neurotransmitters in the gut, so enhancing mental health.
• In Nov 2021, Ombre raised $3M seed round for at-home microbiome tests. Ombre will emphasis on improving its existing products, supply chain, and services and home tests, gut health reports, probiotic formulations, and in-app experience.
• In Nov 2020, Cargill invested US$25m in BioGaia, microbiome collaborations to follow and to accelerate growth and expand microbiome solutions. Cargill Health Technologies (CHT) will benefit from the investment as it expands its offering of health solutions for consumers.
• In Dec 2019, RB and Evolve BioSystems Team Up to Advance Infant Gut Health to sell 'Evivo', which is clinically proven to reduce gut pH, thereby helping suppress the growth of pathogenic bacteria in the infant's gut.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1221

Market Segmentation
Global Human Microbiome-based Gut Health Test and Nutrition Market, by Products, 2022-2030 (Value US$ Mn)
• D2C Gut Health Test
• Probiotic Supplements
• Personalized Nutrition
• Microbiome Modulators
o Ingredients
o Medical Foods
o Therapeutics
Global Human Microbiome-based Gut Health Test and Nutrition Market, by End-User, 2022-2030 (Value US$ Mn)
• Adult
• Maternal
• Infant
Global Human Microbiome-based Gut Health Test and Nutrition Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Human Microbiome-based Gut Health Test and Nutrition Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Request for ToC/Proposal:
Why should purchase this report:
 To receive a key insights and detailed analysis of the prospects for the global human microbiome-based gut health test and nutrition market
 To receive an market overview and future trends of the human microbiome-based gut health test and nutrition market
 To analyze the global human microbiome-based gut health test and nutrition market drivers and challenges
 To get information on the global human microbiome-based gut health test and nutrition market size (Value US$ Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the global human microbiome-based gut health test and nutrition market industry

Get more information: @
https://www.insightaceanalytic.com/report/global-human-microbiome-based-gut-health-test-and-nutrition-market/1221

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

This release was published on openPR.